Home » Topics » Regulatory

Regulatory
RSS

FDA approves Empliciti for previously treated multiple myeloma

Dec. 1, 2015

FDA approves Portrazza for metastatic squamous NSCLC

Nov. 25, 2015

FDA approves Opdivo for renal cell carcinoma

Nov. 24, 2015

Oxaliplatin and capecitabine regimen approved for gastric cancer adjuvant therapy in Japan

Nov. 23, 2015

FDA approves Ninlaro for multiple myeloma

Nov. 23, 2015

First FDA approval of naloxone nasal spray for opioid overdose

Nov. 19, 2015

FDA first to approve Darzalex for multiple myeloma

Nov. 17, 2015

Two Baxalta hemophilia A products approved in Europe, U.S.

Nov. 16, 2015

FDA approves Tagrisso to treat certain patients with NSCLC

Nov. 16, 2015

FDA approves label expansion for Harvoni

Nov. 13, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...